Cheminformatics to Characterize Pharmacologically Active Natural Products

Natural products have a significant role in drug discovery. Natural products have distinctive chemical structures that have contributed to identifying and developing drugs for different therapeutic areas. Moreover, natural products are significant sources of inspiration or starting points to develop new therapeutic agents. Natural products such as peptides and macrocycles, and other compounds with unique features represent attractive sources to address complex diseases. Computational approaches that use chemoinformatics and molecular modeling methods contribute to speed up natural product-based drug discovery. Several research groups have recently used computational methodologies to organize data, interpret results, generate and test hypotheses, filter large chemical databases before the experimental screening, and design experiments. This review discusses a broad range of chemoinformatics applications to support natural product-based drug discovery. We emphasize profiling natural product data sets in terms of diversity; complexity; acid/base; absorption, distribution, metabolism, excretion, and toxicity (ADME/Tox) properties; and fragment analysis. Novel techniques for the visual representation of the chemical space are also discussed.

[1]  M. González-Medina,et al.  Chemical Diversity of Cyanobacterial Compounds: A Chemoinformatics Analysis , 2019, ACS Omega.

[2]  Kolkata,et al.  Evidence-Based Validation of Herbal Medicine , 2016 .

[3]  M. Natália D. S. Cordeiro,et al.  De novo computational design of compounds virtually displaying potent antibacterial activity and desirable in vitro ADMET profiles , 2017, Medicinal Chemistry Research.

[4]  J. Medina-Franco,et al.  Chemoinformatic Approach: The Case of Natural Products of Panama , 2019, Cheminformatics and its Applications.

[5]  José L Medina-Franco,et al.  DataWarrior: an evaluation of the open-source drug discovery tool , 2019, Expert opinion on drug discovery.

[6]  Claude Ostermann,et al.  Design, Synthesis, and Phenotypic Profiling of Pyrano‐Furo‐Pyridone Pseudo Natural Products , 2019, Angewandte Chemie.

[7]  J. Jesús Naveja,et al.  ChemMaps: Towards an approach for visualizing the chemical space based on adaptive satellite compounds , 2017, F1000Research.

[8]  Stephen R. Johnson,et al.  Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.

[9]  B. E. Evans,et al.  Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists. , 1988, Journal of Medicinal Chemistry.

[10]  Xiaoqian Lin,et al.  A Review on Applications of Computational Methods in Drug Screening and Design , 2020, Molecules.

[11]  M. Broggini,et al.  Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 (flt-1) autocrine loop in human leukemia cells MOLT-4 , 2003, Leukemia.

[12]  Mariel P Rico-Hidalgo,et al.  The Acid/Base Profile of a Large Food Chemical Database , 2019, Molecular informatics.

[13]  José L Medina-Franco,et al.  Computational-aided design of a library of lactams through a diversity-oriented synthesis strategy. , 2020, Bioorganic & medicinal chemistry.

[14]  J. Medina-Franco,et al.  Cheminformatics Explorations of Natural Products. , 2019, Progress in the chemistry of organic natural products.

[15]  Jean-Louis Reymond,et al.  Visualization of very large high-dimensional data sets as minimum spanning trees , 2019, Journal of Cheminformatics.

[16]  F. Ntie‐Kang.  An in silico evaluation of the ADMET profile of the StreptomeDB database , 2013, SpringerPlus.

[17]  Thomas Sander,et al.  DataWarrior: An Open-Source Program For Chemistry Aware Data Visualization And Analysis , 2015, J. Chem. Inf. Model..

[18]  José L Medina-Franco,et al.  Reaching for the bright StARs in chemical space. , 2019, Drug discovery today.

[19]  J. Takala,et al.  Angiotensin II in septic shock , 2015, Critical Care.

[20]  P. Zhan,et al.  Fsp3: A new parameter for drug-likeness. , 2020, Drug discovery today.

[21]  J. Kirchmair,et al.  Data Resources for the Computer-Guided Discovery of Bioactive Natural Products , 2017, J. Chem. Inf. Model..

[22]  J. Medina-Franco,et al.  Chemical space and diversity of seaweed metabolite database (SWMD): A cheminformatics study. , 2020, Journal of molecular graphics & modelling.

[23]  José L. Medina-Franco,et al.  Chemical Space and Diversity of the NuBBE Database: A Chemoinformatic Characterization. , 2018, Journal of chemical information and modeling.

[24]  J. Medina-Franco,et al.  Functional group and diversity analysis of BIOFACQUIM: A Mexican natural product database. , 2019, F1000Research.

[25]  Sarah R. Langdon,et al.  Scaffold Diversity of Exemplified Medicinal Chemistry Space , 2011, J. Chem. Inf. Model..

[26]  J. Medina-Franco,et al.  Analysis of the Acid/Base Profile of Natural Products from Different Sources , 2020, Molecular informatics.

[27]  G. Bemis,et al.  The properties of known drugs. 1. Molecular frameworks. , 1996, Journal of medicinal chemistry.

[28]  A Ganesan,et al.  Natural products as a hunting ground for combinatorial chemistry. , 2004, Current opinion in biotechnology.

[29]  Nathan Brown,et al.  On the origins of three-dimensionality in drug-like molecules. , 2016, Future medicinal chemistry.

[30]  José L Medina-Franco.  Towards a unified Latin American Natural Products Database: LANaPD , 2020, Future science OA.

[31]  Fidele Ntie-Kang,et al.  A primer on natural product-based virtual screening , 2019, Physical Sciences Reviews.

[32]  Rajarshi Guha,et al.  Chemoinformatic Analysis of Combinatorial Libraries, Drugs, Natural Products, and Molecular Libraries Small Molecule Repository , 2009, J. Chem. Inf. Model..

[33]  José L. Medina-Franco,et al.  MOLECULAR SIMILARITY ANALYSIS , 2013 .

[34]  Thierry Langer,et al.  In Silico Workflow for the Discovery of Natural Products Activating the G Protein-Coupled Bile Acid Receptor 1 , 2018, Front. Chem..

[35]  Ya Chen,et al.  Cheminformatics in Natural Product‐based Drug Discovery , 2020, Molecular informatics.

[36]  Xiaoli Li,et al.  Machine learning approaches for elucidating the biological effects of natural products. , 2020, Natural product reports.

[37]  Tudor I. Oprea,et al.  The significance of acid/base properties in drug discovery. , 2013, Chemical Society reviews.

[38]  Chen-Yang Jia,et al.  A drug-likeness toolbox facilitates ADMET study in drug discovery. , 2019, Drug discovery today.

[39]  José L. Medina-Franco,et al.  Visualization of the Chemical Space in Drug Discovery , 2008 .

[40]  José L Medina-Franco,et al.  BIOFACQUIM: A Mexican Compound Database of Natural Products , 2018, Biomolecules.

[41]  Mathias Dunkel,et al.  Natural products: sources and databases. , 2006, Natural product reports.

[42]  M. Gill,et al.  Progress in the Chemistry of Organic Natural Products 112 , 2011 .

[43]  J. Jesús Naveja,et al.  Open chemoinformatic resources to explore the structure, properties and chemical space of molecules , 2017 .

[44]  Fernanda I. Saldívar-González,et al.  Inhibitors of DNA Methyltransferases From Natural Sources: A Computational Perspective , 2018, Front. Pharmacol..

[45]  David J Newman,et al.  Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019. , 2020, Journal of natural products.

[46]  J. Gasteiger.  Chemistry in Times of Artificial Intelligence , 2020, Chemphyschem : a European journal of chemical physics and physical chemistry.

[47]  Payal Gupta,et al.  ADMET profiling of geographically diverse phytochemical using chemoinformatic tools. , 2019, Future medicinal chemistry.

[48]  José L. Medina-Franco,et al.  Scaffold Diversity Analysis of Compound Data Sets Using an Entropy-Based Measure , 2009 .

[49]  Norberto Sánchez-Cruz,et al.  Functional group and diversity analysis of BIOFACQUIM: A Mexican natural product database , 2019, F1000Research.

[50]  Andrew R. Leach,et al.  ChEMBL: towards direct deposition of bioassay data , 2018, Nucleic Acids Res..

[51]  J. Medina-Franco,et al.  Lessons from Exploring Chemical Space and Chemical Diversity of Propolis Components , 2020, International journal of molecular sciences.

[52]  Stefan Günther,et al.  StreptomeDB 3.0: an updated compendium of streptomycetes natural products , 2020, Nucleic Acids Res..

[53]  José L. Medina-Franco,et al.  Chemoinformatics-based enumeration of chemical libraries: a tutorial , 2020, Journal of Cheminformatics.

[54]  Schmid,et al.  "Scaffold-Hopping" by Topological Pharmacophore Search: A Contribution to Virtual Screening. , 1999, Angewandte Chemie.

[55]  José L Medina-Franco,et al.  Molecular Scaffold Analysis of Natural Products Databases in the Public Domain , 2012, Chemical biology & drug design.

[56]  José L Medina-Franco,et al.  The many roles of molecular complexity in drug discovery. , 2017, Drug discovery today.

[57]  F. Lovering,et al.  Escape from Flatland 2: complexity and promiscuity , 2013 .

[58]  Terry R Van Vleet,et al.  An Overview of Machine Learning and Big Data for Drug Toxicity Evaluation. , 2020, Chemical research in toxicology.

[59]  Tudor I. Oprea,et al.  The significance of acid/base properties in drug discovery. , 2013, Chemical Society reviews.

[60]  Norberto Sánchez-Cruz,et al.  A Fragment Library of Natural Products and its Comparative Chemoinformatic Characterization , 2020, Molecular informatics.

[61]  José L. Medina-Franco,et al.  Chemoinformatics approaches to assess chemical diversity and complexity of small molecules , 2020 .

[62]  Gerald Maggiora,et al.  The impact of chemoinformatics on drug discovery in the pharmaceutical industry , 2020, Expert opinion on drug discovery.

[63]  Alejandro Speck-Planche,et al.  Chemoinformatics for medicinal chemistry: in silico model to enable the discovery of potent and safer anti-cocci agents. , 2014, Future medicinal chemistry.

[64]  C. Lipinski.  Lead- and drug-like compounds: the rule-of-five revolution. , 2004, Drug discovery today. Technologies.

[65]  Maria Sorokina,et al.  Review on natural products databases: where to find data in 2020 , 2020, Journal of Cheminformatics.

[66]  Miklos Feher,et al.  Property Distributions: Differences between Drugs, Natural Products, and Molecules from Combinatorial Chemistry , 2003, J. Chem. Inf. Comput. Sci..

[67]  J. Medina-Franco,et al.  Cheminformatic characterization of natural products from Panama , 2017, Molecular Diversity.

[68]  A. Andrade-Cetto,et al.  Molecules Isolated from Mexican Hypoglycemic Plants: A Review , 2020, Molecules.

[69]  J. Medina-Franco,et al.  In Silico ADME/Tox Profiling of Natural Products: A Focus on BIOFACQUIM , 2020, ACS omega.

[70]  Douglas E. V. Pires,et al.  pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures , 2015, Journal of medicinal chemistry.

[71]  Michael Bazelot,et al.  Molecular Targets of Cannabidiol in Neurological Disorders , 2015, Neurotherapeutics.

[72]  José L. Medina-Franco,et al.  Chemical space of naturally occurring compounds , 2018, Physical Sciences Reviews.

[73]  Nikolai S. Zefirov,et al.  Progress in visual representations of chemical space , 2015, Expert opinion on drug discovery.

[74]  José L. Medina-Franco,et al.  Consensus Diversity Plots: a global diversity analysis of chemical libraries , 2016, Journal of Cheminformatics.

[75]  J. Medina-Franco,et al.  Discovery and Development of Lead Compounds from Natural Sources Using Computational Approaches , 2015 .

[76]  Sebastian Schneckener,et al.  Prediction of Oral Bioavailability in Rats: Transferring Insights from in Vitro Correlations to (Deep) Machine Learning Models Using in Silico Model Outputs and Chemical Structure Parameters , 2019, J. Chem. Inf. Model..

[77]  Kiran K. Telukunta,et al.  Pharmacoinformatic Investigation of Medicinal Plants from East Africa , 2020, Molecular informatics.

[78]  P. Wipf,et al.  Stochastic voyages into uncharted chemical space produce a representative library of all possible drug-like compounds. , 2013, Journal of the American Chemical Society.

[79]  J. Jesús Naveja,et al.  Getting SMARt in drug discovery: chemoinformatics approaches for mining structure–multiple activity relationships , 2017 .